Clinical, Immunophenotypic, and Genetic Characterization of Small Lymphocyte–Like Plasma Cell Myeloma
- 1 February 2010
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 133 (2), 265-270
- https://doi.org/10.1309/ajcpus3prrt5zxvs
Abstract
We reviewed bone marrow studies from 351 multiple myeloma (MM) cases, selecting 12 cases (3.4%) with predominantly small lymphocyte–like morphologic features resembling B-cell lymphoma, and correlated their genetic and clinical features. All exhibited a diffuse interstitial pattern of marrow involvement. Small lymphocyte–like plasma cells were all CD45– with bright CD38 and CD138 expression and CD20 expression in 5 cases. No case had an increase in bone marrow B lymphocytes by flow cytometry. Of 12 cases, 9 were classified as the CD-2 molecular class by gene expression profiling (GEP). The 29 CD-2 class cases with (n = 9) and without (n = 20) small lymphocyte–like features could not be discerned from one another using global GEP. Event-free, but not overall, survival was significantly better in cases with small lymphocyte–like features among those sharing the CD-2 subtype. Small lymphocyte–like MM is a rare, morphologically challenging variant distinguished from B-cell lymphoma by lack of CD45 and presence of CD138 and the clinical presentation of MM. Most cases share a common GEP signature dominated by hyperexpression of cyclin D1 or cyclin D3 genes, with increased expression of the B-cell genes CD20 and VPREB3.Keywords
This publication has 11 references indexed in Scilit:
- The molecular classification of multiple myelomaBlood, 2006
- Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarrayLaboratory Investigation, 2004
- t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myelomaLeukemia, 2003
- CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myelomaBlood, 2003
- Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patientsBlood, 2002
- Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cellsBlood, 2002
- The (11;14)(q13;q32) Translocation in Multiple MyelomaAmerican Journal of Clinical Pathology, 2000
- Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphologyLeukemia Research, 1999
- Correlations between karyotype and cytologic findings in multiple myeloma.1995
- Histologic Classification and Staging of Multiple Myeloma: A Retrospective and Prospective Study of 674 CasesAmerican Journal of Clinical Pathology, 1987